| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |